GLAXOBSEGLAXOSMITHKLINE PHARMA LT· PharmaceuticalsMinimalNeutral
Announced Mon, 12 Oct, 2026 · 16:29 IST

Compliance certificate for share dematerialisation, Q2 FY27

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.7%Reaction day
₹2520.40
prior close
₹2525.10
announcement price
After-mkt
timing
Nifty Midcap 150market+1.0%-0.3% vs market
Pharmaceuticals peers, median of 168sector-0.3%+1.0% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Midcap 150 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.1
15m
-0.0
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.7+1.0-0.3-0.3+1.0
Next day
+0.7+0.9-0.2-0.3+1.0
2d
+0.4+0.6-0.2-1.2+1.6
3d
+1.9+0.5+1.3-1.0+2.9
4d
-0.8-0.6-0.2-2.6+1.8
5d
-2.8-1.9-0.8-4.0+1.3
1w
-4.1-4.8+0.6-6.5+2.4
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KFin Technologies, the company's Registrar and Share Transfer Agent, submitted a certificate to BSE and NSE for the quarter ended September 30, 2026 under SEBI regulation 74(5). It confirms that share dematerialisation requests received from depository participants were processed and confirmed, physical certificates were cancelled after verification, and the register of members was updated with the depository as owner within 30 days. This is a standard regulatory compliance submission.

Likely market impact

Routine compliance filing with no impact on business, financials, or shareholders.